Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity

Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity

Modified Look-Locker Inversion recovery (MOLLI) T1 mapping sequences can be useful in cardiac and liver tissue characterization but determining underlying water T1 is confounded by iron, fat and frequency offsets. This article proposes an algorithm that provides an independent water MOLLI T1 (referr...

Bibliografske podrobnosti
Main Authors:	Mozes, F, Tunnicliffe, E, Moolla, A, Marjot, T, Levick, C, Pavlides, M, Robson, M
Format:	Journal article
Izdano:	John Wiley and Sons, Inc. 2018

Podobne knjige/članki

Influence of fat on liver T1 measurements using modified Look–Locker inversion recovery (MOLLI) methods at 3T
od: Mozes, F, et al.
Izdano: (2016)

A model for hepatic fibrosis: The competing effects of cell loss and iron on shortened Modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver
od: Tunnicliffe, E, et al.
Izdano: (2016)

Hydration and glycogen affect T1 relaxation times of liver tissue
od: Mózes, FE, et al.
Izdano: (2021)

T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences.
od: Robson, M, et al.
Izdano: (2013)

T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences
od: Robson, MD, et al.
Izdano: (2013)

Differences between T1 and corrected T1 cannot be attributed to iron-correction only
od: Mózes, FE, et al.
Izdano: (2021)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
od: Jayaswal, A, et al.
Izdano: (2020)

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
od: Levick, C, et al.
Izdano: (2018)

Are T1 values to characterize myocardial tissue equivalent between various sequences: comparison of MOLLI, shMOLLI, 3'5-MOLLI and SASHA
od: Puntmann Valentina O, et al.
Izdano: (2013-01-01)

T1- and ECV-mapping in clinical routine at 3 T: differences between MOLLI, ShMOLLI and SASHA
od: Julius F. Heidenreich, et al.
Izdano: (2019-08-01)

Improved T1 fitting with the MOLLI sequence
od: Cooper Mitchell A, et al.
Izdano: (2013-01-01)

Age-gender reference values of native myocardial T1 at 1.5T and 3T: comparison of MOLLI and shMOLLI
od: Dabir Darius, et al.
Izdano: (2013-01-01)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.
od: Karamitsos, T, et al.
Izdano: (2012)

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?
od: Chin, J, et al.
Izdano: (2016)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
od: Karamitsos Theodoros, et al.
Izdano: (2012-02-01)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
od: Selvaraj, E, et al.
Izdano: (2019)

Spleen T1 and spleen diameter criteria can identify and exclude oesophageal varices accurately
od: Levick, C, et al.
Izdano: (2019)

Standardization of myocardial T1 time measurements in clinical setting using MOLLI, shMOLLI and LL at 1.5T and 3T - the CONSEPT study
od: Rogers Toby, et al.
Izdano: (2013-01-01)

A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
od: Moolla, A, et al.
Izdano: (2019)

Reply to: non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
od: Pavlides, M, et al.
Izdano: (2021)

Comparison of liver iron concentration calculated from R2* at 1.5 T and 3 T
od: Pickles, E, et al.
Izdano: (2022)

Application of a high resolution T1 mapping with MOLLI (hrMOLLI) in patients in clinical setting: a reproducibility study
od: Pastor Ana, et al.
Izdano: (2012-02-01)

Myocardial iron quantification using modified Look-Locker inversion recovery (MOLLI) T1 mapping at 3 Tesla
od: Camargo GC, et al.
Izdano: (2013-01-01)

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
od: Marjot, T, et al.
Izdano: (2019)

Comparison of MOLLI and ShMOLLI in Terms of T1 Reactivity and the Relationship between T1 Reactivity and Conventional Signs of Response during Adenosine Stress Perfusion CMR
od: Esin Gezmiş, et al.
Izdano: (2020-09-01)

Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.
od: Piechnik, S, et al.
Izdano: (2013)

Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
od: Levick, C, et al.
Izdano: (2018)

Optimal flip angles for in vivo liver 3D T1 mapping and B1+ mapping at 3T.
od: Belsley, G, et al.
Izdano: (2023)

A Tribute to Molly
od: Lois Dyer
Izdano: (1998-05-01)

Microstructural inhomogeneity of electrical conductivity in subcutaneous fat tissue.
od: Ilja L Kruglikov
Izdano: (2015-01-01)

Molly reborn in C++ and R
od: S.J.R. Woodward, et al.
Izdano: (2020-01-01)

Validation of the shortened modified look locker inversion recovery (Sh-MOLLI) sequence for cardiac gated T1 mapping
od: Robson Matthew D, et al.
Izdano: (2010-01-01)

Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI.
od: Piechnik, S, et al.
Izdano: (2012)

Inhomogeneous superconductivity in thin crystals of FeSe1−xTex (x = 1.0, 0.95, and 0.9)
od: Ritsuko Eguchi, et al.
Izdano: (2020-01-01)

MRI in liver cirrhosis
od: Osama Alzoubi, et al.
Izdano: (2022-06-01)

Phosphodiester content measured in human liver by in vivo (31) P MR spectroscopy at 7 tesla.
od: Purvis, L, et al.
Izdano: (2017)

Improving the robustness of MOLLI T1 maps with a dedicated motion correction algorithm
od: Gaspar Delso, et al.
Izdano: (2021-09-01)

Molly Bloom and the Comedy of Remarriage
od: Camelia Raghinaru
Izdano: (2012-12-01)

A Conversation with Molly Stevens
od: Rachel Brazil
Izdano: (2021-02-01)

Continuous quantitative mapping of multi-organ T1 relaxation times with ShMOLLI to assess dose response in respiratory challenges at 3T
od: Piechnik SK, et al.
Izdano: (2013-01-01)